EMA Features eSignature Workshops
EMA webminars on eSignatures
The European Medicines Agency (EMA) has announced it is hosting a series of ‘webminars’ to assist users of its eSignature solution. The sessions start at 11 am and last up to 60 minutes, and will take place on January 22, February 5 and 19, and March 5.
The EMA has introduced capabilities to produce digitally signed electronic documents and to verify incoming digitally signed electronic documents from the areas of Scientific Advice, Orphan Medicines and Pediatric Medicines in portable document format (PDF). It provides specific PDF-certified electronic application forms that enable the pharmaceutical industry to digitally sign and submit using a PDF reader application. These capabilities are part of the strategy to increase electronic document-only exchanges with the pharmaceutical industry and regulatory bodies.
Industry will benefit by being able to exchange digitally signed documents, based upon specific acceptability criteria, according to EMA. The exchange of digitally signed electronic documents could bring cost savings to industry by removing the need to print documentation and incur courier charges. Electronic document exchanges also may increase efficiency and eliminate the requirement for archiving paper documents.
For further details about the webminars click here.
Semaglutide Significantly Improves Steatohepatitis, Fibrosis in Phase III MASH Trial
May 2nd 2025Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly semaglutide improved liver histology, metabolic markers, and weight loss in patients with biopsy-confirmed metabolic dysfunction–associated steatohepatitis and stage 2 or 3 fibrosis.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
